Paul J. Hastings, Chairman & CEO at OncoMed Pharmaceuticals Inc (OMED), sold 1,398 shares at $4.26 ($6K) on 2017-10-10, disclosed to the SEC on 2017-10-12.
Open-market sale of $6k OMED by Chairman & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.24 | 1,346 | $6K | 96.3% |
| 2 | $4.26 | 52 | $222 | 3.7% |
| Total | $4.24 avg | 1,398 | $6K | 100% |
| Filing → |
| NKTX | SELL | 2025-06-20 | $3K | — | Filing → |
| NKTX | SELL | 2025-01-17 | $38K | — | Filing → |
| NKTX | SELL | 2024-06-20 | $10K | — | Filing → |